BREYANZI is a Kit in the Cellular Therapy category. It is labeled and distributed by Juno Therapeutics, Inc.. The primary component is .
| Product ID | 73153-900_0dc7e1de-7a6d-4931-bcc1-f82c5edf6d2b |
| NDC | 73153-900 |
| Product Type | Cellular Therapy |
| Proprietary Name | BREYANZI |
| Generic Name | Lisocabtagene Maraleucel |
| Dosage Form | Kit |
| Marketing Start Date | 2021-02-05 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125714 |
| Labeler Name | Juno Therapeutics, Inc. |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2021-02-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BREYANZI 90300948 not registered Live/Pending |
JUNO THERAPEUTICS, INC. 2020-11-05 |
![]() BREYANZI 90300931 not registered Live/Pending |
JUNO THERAPEUTICS, INC. 2020-11-05 |
![]() BREYANZI 88569196 not registered Live/Pending |
JUNO THERAPEUTICS, INC. 2019-08-07 |
![]() BREYANZI 88077381 not registered Live/Pending |
Celgene Corporation 2018-08-14 |